<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p>Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease of unknown cause. An external trigger (e.g. cigarette smoking, infection, or trauma) triggers an autonomic reaction, leading to synovial hypertrophy and chronic joint inflammation along with the prospect for extra-articular manifestations. It is believed to occur in genetically susceptible individuals and more common in middle aged women. </p><p>Cause </p><ul><li>Unknown </li><li>Autoimmune disorder </li><li>Likely a combination of genetic and environmental factors </li></ul><p>Symptoms </p><ul><li>Joint stiffness</li><li>Painful joints </li><li>Swelling of affected joints </li><li>Deformity of affected joints </li><li>Limitation of motion </li><li>Skin nodules </li><li>Difficulty in breathing </li><li>Easy fatigability</li></ul><p>Signs </p><ul><li>Persistent symmetric polyarthritis (synovitis) of hands and feet</li><li>Joint stiffness </li><li>Joint tenderness </li><li>Joint swelling </li><li>Joint deformity </li><li>Limitation of joint movement </li><li>Rheumatoid nodules </li><li>Signs relating to extra-articular involvement e.g. lung disease, uveitis, pericardial or pleural effusions</li></ul><p>Investigations </p><ul><li>FBC, ESR</li><li>C-reactive protein level </li><li>Rheumatoid Factor assay </li><li>Antinuclear antibody(ANA) assay</li><li>Anti- Cyclic Citrullinated Peptide (Anti-CCP)</li><li>Joint aspiration and analysis of synovial fluid </li><li>Hepatitis B and C tests </li><li>HIV test</li><li>X-rays of hands and feet</li><li> MRI of cervical spine (to detect subluxation)</li><li>Ultrasonography of joints </li></ul><p>Treatment</p><p>Treatment objectives </p><ul><li>To reduce pain, swelling and stiffness</li><li>To prevent deformities </li><li>To delay disease progression and long-term complications</li><li>To reduce drug side effects </li></ul><p>Non-pharmacological treatment </p><ul><li>Heat and cold therapies </li><li>Orthotics and splints </li><li>Physiotherapy </li><li>Occupational therapy </li><li>Adaptive equipment </li><li>Joint-protection education </li><li>Counselling and education </li><li>Synovectomy </li><li>Tenosynovectomy </li><li>Tendon realignment </li><li>Reconstructive surgery or arthroplasty </li><li>Arthrodesis </li></ul><p><strong>Pharmacological treatment </strong></p><p><strong>A. Symptoms present more than 6 weeks of antibody positive </strong></p><p>1st Line Treatment</p><p>Evidence Rating: [B]</p><ul><li>Prednisolone, oral, 0.5-1mg/kg body weight </li></ul><p><strong>Caution</strong></p><p>Take corticosteroids after food. </p><p>High-dose glucocorticoids may cause insomnia, immediate-release formulation is typically administered in morning to coincide with circadian rhythm.</p><p><strong>And </strong></p><ul><li>Omeprazole, oral, </li></ul><p>Adults </p><p>20mg daily </p><p>Children</p><p>&gt;20kg;       20mg daily </p><p>10-20kg     10mg daily </p><p>5-10kg         5mg daily</p><p><strong>Or</strong></p><ul><li>Esomeprazole, oral,</li></ul><p>Adults</p><p>20-40 mg daily </p><p>Children</p><p>12-18 years;           20-40mg daily </p><p>1-12 years;             10-20mg daily </p><p>&lt;1 year;                  not recommended </p><p> </p><p>And</p><ul><li>Diclofenac, oral, </li></ul><p>Adults </p><p>50 mg 8hourly 0r 100 mg 12 hourly as required </p><p>Children </p><p>&gt;12 year;                50 mg 12 hourly as required </p><p>&lt;12years;               not recommended </p><p><strong>Or</strong></p><ul><li>Paracetamol, oral ,</li></ul><p>Adults</p><p>500 mg-1g 6-8 hourly as required </p><p>Children</p><p>6-12 years;250-500mg 6-8 hourly as required </p><p>1-5 years;  120-250 mg 6-8 hourly as required </p><p>3 months-1 year;            60-120mg 6-8 hourly as required </p><p> </p><p><strong>And</strong></p><ul><li>Calcium  supplements</li></ul><p>Adults and Children </p><p>As required </p><p><strong>B. Maintenance treatment for symptoms present more than 6 weeks or antibody positive </strong></p><p>1st Line Treatment </p><p>Evidence Rating: [B]</p><ul><li>Hydroxychloroquine, consult specialist </li><li>Sulfasalazine, consult specialist</li><li>Methotrexate, consult specialist</li><li>Leflunomide, consult specialist</li></ul><p> </p><p><strong>Or </strong></p><ul><li>Etanercept, consult specialist</li><li>Infliximab, consult specialist</li><li>Adalimumb, consult specialist</li><li>Certolizumab, consult specialist</li><li>Golimumb, consult specialist</li></ul><p><strong>Or</strong></p><p> </p><ul><li>Rituximab, consult specialist</li><li>Anakinra, consult specialist</li><li>Abatacept, consult specialist </li><li>Tocilixumab, consult specialist</li><li>Tofacitinib, consult specialist </li></ul><p> </p><p>2nd Line Treatment </p><p>Evidence Rating: [C]</p><ul><li>Cyclosporine, consult specialist</li><li>Azathioprine, consult specialist</li><li>Gold salts, consult specialist</li><li>D-penicillamine, consult specialist </li><li>Minocycline , consult specialist</li></ul><p> </p><p><strong>REFERRAL CRITERIA</strong></p><p>Refer all cases to a physician specialist or rheumatologist.</p>
</body>
</html>
